Type

Issue

Tag

Spines ’R’ Us: The evidence and business behind spinal fusions

In Modern Healthcare, Lisa Gillespie reviews the evidence and incentives that drive some hospitals to overuse spinal fusion procedures. She cites research from the Lown Institute in collaboration with Australian academics published this year, which shows that spinal fusions for stenosis and other conditions not backed by strong evidence of effectiveness are associated with poor outcomes. Out of seven low-value procedures, inpatient spinal fusions were affiliated the most with hospital-acquired conditions, adverse patient safety indicators and unplanned hospital admissions after outpatient procedures, their review of Medicare claims from 2016 to 2018 found. “If, on average, this thing doesn’t work, the burden is on you to tell me why for this particular patient, it’s going to work, beyond just a faith-based argument,” said Dr. Vikas Saini, president of the Lown Institute.

“The public expects their doctors to make care decisions, but I will also say the public expects doctors to make their medical decisions on the basis of the best interest of the patient,” Saini said. “It is now going to become more relevant for hospital administrators to do their homework on appropriateness and inappropriateness.”

More

Tackling the growing problem of overmedication

According to a report by the Lown Institute, a nonprofit think tank, 42 percent of all older adults in the US take five or more prescription medications a day. Almost 20 percent take 10 drugs or more, and over the past 20 years, incidences of polypharmacy have tripled across the country. If trends continue, it’s estimated that polypharmacy will lead to nearly 150,000 premature deaths in the US over the next decade, according to the report by the Lown Institute. It will also be responsible for at least 4.6 million hospitalizations in the US between 2020 and 2030, costing around $62 billion, the report predicted. More

Recent studies in antibiotic stewardship

A single-center study of terminal cancer patients found a high rate of antibiotic use within the last 30 days of life, with significantly lower use among those who asked for limited antimicrobial treatment, researchers reported yesterday in Open Forum Infectious Diseases. More